浙江诚意药业股份有限公司2025年第一次临时股东会决议公告

Group 1 - The first extraordinary general meeting of shareholders for 2025 was held on August 11, 2025, at the company's research and development building in Wenzhou, Zhejiang Province [2] - The meeting was convened by the board of directors and was conducted through a combination of on-site and online voting, presided over by the chairman, Mr. Yan Yiyi [2][3] - All nine current directors attended the meeting, along with the board secretary and some senior executives [3] Group 2 - Three proposals were reviewed and approved during the meeting, including the draft of the 2025 employee stock ownership plan and its management measures [4][5] - The voting results indicated that all proposals received more than half of the valid voting rights, and the meeting ensured separate counting for minority investors [5] - Related shareholders recused themselves from voting on the proposals to maintain compliance with regulations [5] Group 3 - The meeting was witnessed by lawyers from Shanghai Jintiancheng Law Firm, who confirmed that the procedures and voting processes complied with relevant laws and regulations [5]